Emfo »

Avenue Therapeutics shares owned by Emfo

Quarter-by-quarter ownership of Avenue Therapeutics (ATXI) shares owned by Emfo from 13F filings

Historical chart of Emfo investment in Avenue Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avenue Therapeutics held by Emfo consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avenue Therapeutics by Emfo

Quarter filed Position value Share count Share price at filing
2024-06-30 $28 8 3.50

More positions owned by Emfo

Apple (AAPL)
Ares Capital Corporation (ARCC)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Chicago Atlantic Real Estate Fin (REFI)
JPMorgan Chase & Co. (JPM)
Goldman Sachs (GS)
Amgen (AMGN)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Merck & Co (MRK)
NVIDIA Corporation (NVDA)
Verizon Communications (VZ)

View all positions for Emfo

Top funds holding Avenue Therapeutics

Armistice Capital
Moss Adams Wealth Advisors
Tower Research Capital
Wells Fargo & Company
Bank of America Corporation
Emfo
Jpmorgan Chase & Co

View all funds holding Avenue Therapeutics